IRVINE, Calif.--(BUSINESS WIRE)--CTC Global announced today that its testing laboratory has received a Certificate of Accreditation under ISO/IEC 17025 from the prestigious International Accreditation ...
Blood test for breast cancer patients will be performed by Biocept and analyzed by Clarient. Biocept and Clarient have entered a collaboration to commercialize a blood test for circulating tumor cells ...
Washington, DC – Researchers at Georgetown Lombardi Comprehensive Cancer Center say the number of circulating tumor cells (CTCs) in the blood is a "powerful predictor" to help physicians more reliably ...
This new CELLSEARCH Circulating Tumor Cell (CTC) test is now available as a Research Use Only (RUO) lab service in North America and Europe. It is currently intended for basic and pharmaceutical ...
A new meta-analysis adds to the data supporting the use of a blood test that measures circulating tumor cells (CTCs) as a quick way to find out whether or not a treatment for metastatic breast cancer ...
A simple blood test that detects tumor cells circulating in the blood shows promise as a new way to predict high or low risk of a breast cancer relapse. This is according to data presented today at ...
Imagine using a blood test to give you the odds your breast cancer will return. A new German study brings that possibility a step closer. Researchers have found it may be possible to look for "markers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback